{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T00:45:45Z","timestamp":1789865145086,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2700,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.seizure.2005.12.004","type":"journal-article","created":{"date-parts":[[2006,1,19]],"date-time":"2006-01-19T14:07:22Z","timestamp":1137679642000},"page":"214-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study"],"prefix":"10.1016","volume":"15","author":[{"given":"Angelo","family":"Labate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Colosimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Gambardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Leggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Quattrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.seizure.2005.12.004_bib1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/mds.870150702","article-title":"The clinical spectrum of posthypoxic myoclonus","volume":"15","author":"Frucht","year":"2000","journal-title":"Mov Disord"},{"key":"10.1016\/j.seizure.2005.12.004_bib2","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1212\/WNL.57.6.1112","article-title":"A pilot tolerability and efficacy study of levetiracetam in patients with cronic myoclonus","volume":"57","author":"Frucht","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.12.004_bib3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000110193.78872.DD","article-title":"Levetiracetam in progressive myoclonic epilepsy. An exploratory study in 9 patients","volume":"62","author":"Crest","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.12.004_bib4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1212\/WNL.56.3.411","article-title":"Suppression of post-hypoxic and post encephalitic myoclonus with levetiracetam","volume":"56","author":"Krauss","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.12.004_bib5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1212\/01.WNL.0000058755.38892.80","article-title":"Efficacy of levetiracetam in a patient with Unverricht-Lundborg progressive myoclonic epilepsy","volume":"60","author":"Kinrions","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2005.12.004_bib6","doi-asserted-by":"crossref","unstructured":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 1981;22:489\u2013501.","DOI":"10.1111\/j.1528-1157.1981.tb06159.x"},{"issue":"6","key":"10.1016\/j.seizure.2005.12.004_bib7","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.0013-9580.2004.56902.x","article-title":"Antimyoclonic effect of Levetiracetam in 13 patients with Unverricht-Lundborg disease: clinical observations","volume":"45","author":"Magaudda","year":"2004","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2005.12.004_bib8","first-page":"254","article-title":"Levetiracetam: exacerbation of epilepsy","volume":"42","author":"Goldestein","year":"2001","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.seizure.2005.12.004_bib9","first-page":"184","article-title":"Exacerbation of seizures: any relationship to dose escalation of levetiracetam (Keppra)?","volume":"42","author":"Montorius","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2005.12.004_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1684\/j.1950-6945.2000.tb00445.x","article-title":"Antimyoclonic effect of levitiracetam","volume":"2","author":"Genton","year":"2000","journal-title":"Epileptic Disord"},{"issue":"6","key":"10.1016\/j.seizure.2005.12.004_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1212\/01.WNL.0000154515.94346.89","article-title":"International Lamotrigine Pregnancy Registry Scientific Advisory Committee. Lamotrigine and the risk of malformations in pregnancy","volume":"64","author":"Cunnington","year":"2005","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2005.12.004_bib12","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1528-1167.2005.54804.x","article-title":"Levetiracetam concentrations in serum and in breast milk at birth and during lactation","volume":"46","author":"Johannessen","year":"2005","journal-title":"Epilepsia"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105002281?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131105002281?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:34:59Z","timestamp":1761010499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131105002281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":12,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S1059131105002281"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2005.12.004","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levetiracetam in patients with generalised epilepsy and myoclonic seizures: An open label study","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2005.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}